Skip to main content
TipRanks
Go Ultimate75% OFF

Vaso (VASO) AI Stock Analysis

29 Followers
VASO

Vaso

(Other OTC:VASO)

Select Model
Rating:62Neutral
Price Target:$0.29â–²(5.93% Upside)
Action:reiterated
Date:08/20/26

The overall score of 62 reflects a company with a solid financial foundation but significant operational challenges. The primary positive driver is strong bullish momentum in the stock price, supported by a robust, debt-free balance sheet. These strengths are counterbalanced by the primary risk: a clear downward trend in revenue and profitability that has led to volatile cash flows. The reasonable P/E valuation provides some support but is contingent on a turnaround that is not yet evident in the financial statements.

Positive Factors
Conservative balance sheetLow leverage and a healthy equity base provide financial flexibility and reduce refinancing risk. This balance-sheet resilience can help Vaso withstand operating volatility and preserve capacity for investment or other capital allocation over the next several quarters.
Negative Factors
TTM revenue declineThe sharp TTM revenue decline signals weaker demand or reduced business activity compared with the prior year. If sustained, lower revenue can limit operating leverage, reduce reinvestment capacity, and make recovery in earnings less dependable.

Vaso (VASO) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%VASO+92.86%SPY+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$47.58M
Dividend Yield
―
Average Volume (3M)
125.30K
Price to Earnings (P/E)
16.7
Beta (1Y)
0.56
Revenue Growth
-23.30%
EPS Growth
-140.14%
Country
US
Employees
282
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Vaso Business Overview & Revenue Model

Company Description

Vaso Corporation is a diversified enterprise engaged in both the healthcare equipment and information technology industries, serving markets within the United States and globally. The company's operations are structured across three primary divisions...

Vaso Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is strong with minimal debt and growing equity (Score 75). However, the income statement shows declining revenue and severe margin compression (Score 35), and cash flow is volatile with a recent dramatic decline (Score 40). The overall profile is of a well-capitalized company facing significant operational headwinds.

Income Statement

35Negative

Balance Sheet

75Positive

Cash Flow

40Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Dec 2022Dec 2021
Income Statement
Total Revenue80.22M89.10M86.77M81.02M80.02M75.58M
Gross Profit51.98M54.67M52.05M50.59M48.48M43.13M
EBITDA413.00K-423.00K2.10M5.95M8.38M6.66M
Net Income2.79M1.57M951.00K4.80M11.87M6.10M
Balance Sheet
Total Assets85.91M88.35M82.94M75.76M72.66M52.36M
Cash, Cash Equivalents and Short-Term Investments38.29M35.05M26.27M25.32M20.32M6.65M
Total Debt1.79M1.81M2.38M2.06M1.80M1.39M
Total Liabilities56.70M58.92M55.24M48.91M49.78M41.05M
Stockholders Equity29.21M29.43M27.70M26.84M22.88M11.31M
Cash Flow
Free Cash Flow6.90M8.35M1.83M4.57M13.85M7.40M
Operating Cash Flow7.86M9.27M3.28M5.30M14.42M7.82M
Investing Cash Flow-821.00K-725.00K11.73M-5.66M-8.42M-260.00K
Financing Cash Flow-834.00K248.00K-89.00K-134.00K-230.00K-8.33M

Vaso Technical Analysis

Technical Analysis SentimentNegative
Last Price0.27

Price Trends

50DMA0.29Negative
100DMA0.26Positive
200DMA0.22Positive

Market Momentum

MACD-0.00Positive
RSI39.09Neutral
STOCH37.84Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VASO, the sentiment is Negative. The current price of 0.27 is below the 20-day moving average (MA) of 0.29, below the 50-day MA of 0.29, and above the 200-day MA of 0.22, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 39.09 is Neutral, neither overbought nor oversold. The STOCH value of 37.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VASO.

Vaso Risk Analysis

Vaso disclosed 32 risk factors in its most recent earnings report. Vaso reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Vaso Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

VASO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
VASOVASO62Neutral$47.58M16.675.59%―-23.30%-140.14%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
BEATBEAT43Neutral$21.55M-0.81-402.72%――38.22%
VSEEVSEE40Underperform$175.37K-0.01-400.87%―-30.28%38.11%
HCTIHCTI38Underperform$2.89M-0.00-43.51%―141.89%99.35%

* Healthcare Sector Average

Performance Comparison

-100%-50%0%50%100%VASOHCTIBEATVSEEBFRGMGRXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
VASO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
VASOVaso Corp0.270.1392.86%
HCTIHealthcare Triangle, Inc.3.16-2156.84-99.85%
BEATHeartbeam, Inc.0.34-1.34-79.76%
VSEEVsee Health, Inc.0.20-51.80-99.62%
BFRGBullFrog AI Holdings, Inc.0.42-0.45-51.72%
MGRXMangoceuticals, Inc.0.15-0.99-87.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 20, 2026